Literature DB >> 29038935

Clinical knowledge of community pharmacists in Croatia for detecting drug-related problems.

Lovre Zekan1,2, Arijana Mestrovic2,3, Ana Seselja Perisin2, Mate Portolan1,2,4, Nada Jambrek5, Silvana Jager6, Martina Sepetavc7, Darko Modun8.   

Abstract

Background Drug-related problems (DRPs) interfere with patient's health outcomes and have a negative impact on healthcare resources. Successful management of DRPs is an essential part of pharmaceutical care. Pharmacists should have adequate clinical knowledge in order to effectively implement pharmaceutical care and manage DRPs. Objective To determine the clinical knowledge of community pharmacists in Croatia to detect and resolve DRPs. Method A sample of 302 community pharmacists have anonymously and voluntarily completed the validated survey-based clinical knowledge measurement tool. For each completed survey, all statements were scored individually, and a total score was calculated. The lowest possible total score was 0 and the highest was 80. Higher survey score indicates a higher level of clinical knowledge to detect and resolve a DRP. Results All community pharmacists had a mean score of 45.5 ± 8.6, while pharmacists from a pharmacy chain with mandatory education had a higher mean score of 50.2 ± 6.5. Multivariate linear regression revealed that only additional education (β = 0.272, p < 0.001) is associated with a higher mean score, while age and gender have no influence on the survey score. Conclusion Additional education of community pharmacists could increase their clinical knowledge to detect and resolve DRPs.

Entities:  

Keywords:  Clinical knowledge; Community pharmacy; Croatia; Drug-related problems; Survey

Mesh:

Year:  2017        PMID: 29038935     DOI: 10.1007/s11096-017-0546-z

Source DB:  PubMed          Journal:  Int J Clin Pharm


  8 in total

1.  Factors influencing the detection rate of drug-related problems in community pharmacy.

Authors:  T Westerlund; A B Almarsdóttir; A Melander
Journal:  Pharm World Sci       Date:  1999-12

2.  A clinical knowledge measurement tool to assess the ability of community pharmacists to detect drug-related problems.

Authors:  Mackenzie Williams; Gregory M Peterson; Peter C Tenni; Ivan K Bindoff
Journal:  Int J Pharm Pract       Date:  2012-02-02

3.  Community pharmacists' assessments and recommendations for treatment in four case scenarios.

Authors:  G D Lamsam; M A Kropff
Journal:  Ann Pharmacother       Date:  1998-04       Impact factor: 3.154

4.  The Development of the Croatian Competency Framework for Pharmacists.

Authors:  Iva Mucalo; Maja Ortner Hadžiabdić; Tihana Govorčinović; Martina Šarić; Andreia Bruno; Ian Bates
Journal:  Am J Pharm Educ       Date:  2016-10-25       Impact factor: 2.047

5.  Pharmaceutical care: the PCNE definition 2013.

Authors:  Samuel S Allemann; J W Foppe van Mil; Lea Botermann; Karin Berger; Nina Griese; Kurt E Hersberger
Journal:  Int J Clin Pharm       Date:  2014-04-20

6.  Drug-related morbidity and mortality. A cost-of-illness model.

Authors:  J A Johnson; J L Bootman
Journal:  Arch Intern Med       Date:  1995-10-09

7.  Effect of a training program on community pharmacists' detection of and intervention in drug-related problems.

Authors:  J D Currie; E A Chrischilles; A K Kuehl; R A Buser
Journal:  J Am Pharm Assoc (Wash)       Date:  1997 Mar-Apr

8.  Health care professionals' and students' attitude toward collaboration between pharmacists and physicians in Croatia.

Authors:  Ana Seselja-Perisin; Arijana Mestrovic; Ivana Klinar; Darko Modun
Journal:  Int J Clin Pharm       Date:  2016-02
  8 in total
  2 in total

1.  Identifying Gaps in Community Pharmacists' Competence in Medication Risk Management in Routine Dispensing.

Authors:  Sonja Kallio; Tiina Eskola; Marja Airaksinen; Marika Pohjanoksa-Mäntylä
Journal:  Innov Pharm       Date:  2021-02-11

2.  Improving community pharmacists' clinical knowledge to detect and resolve drug-related problems in Croatia: a before/after survey study investigating the efficacy of an educational intervention.

Authors:  Lovre Zekan; Arijana Mestrovic; Ana Seselja Perisin; Josipa Bukic; Dario Leskur; Doris Rusic; Darko Modun
Journal:  BMJ Open       Date:  2020-06-01       Impact factor: 2.692

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.